SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,934,000 | -45.3% | 335,000 | -36.8% | 13.38% | -13.5% |
| Q2 2021 | $16,319,000 | +16.7% | 530,000 | -0.7% | 15.46% | +38.9% |
| Q1 2021 | $13,980,000 | +19.5% | 534,000 | +14.8% | 11.13% | +43.7% |
| Q4 2020 | $11,699,000 | -13.9% | 465,000 | -13.6% | 7.75% | -38.1% |
| Q4 2016 | $13,591,000 | +44.8% | 538,241 | +41.8% | 12.52% | +79.3% |
| Q3 2016 | $9,386,000 | -29.9% | 379,533 | -42.3% | 6.98% | +13.7% |
| Q2 2016 | $13,394,000 | -2.8% | 657,533 | -27.2% | 6.14% | -4.8% |
| Q1 2016 | $13,779,000 | -2.5% | 903,533 | -14.1% | 6.45% | -3.0% |
| Q4 2015 | $14,129,000 | +28.7% | 1,051,277 | +34.3% | 6.65% | +2.4% |
| Q3 2015 | $10,982,000 | – | 782,746 | – | 6.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |